← Open Payments lookup

ASHLY KOEHLER: Open Payments

NPI 1326679572 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$934 in 56 payments from 10 companies in 2025. Trend: 2023 $25 · 2024 $858 · 2025 $934

Food & beverage: $934
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$250
ABBVIE INC.15$219
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$136
Teva Pharmaceuticals USA, Inc.4$77
Neurocrine BioSciences, Inc.3$67
Supernus Pharmaceuticals, Inc.4$58
Lundbeck LLC3$50
Collegium Pharmaceutical, Inc.2$45
Vanda Pharmaceuticals Inc.1$17
Alkermes, Inc.1$16

Products named: REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, INGREZZA, Qelbree, Jornay PM, FANAPT.

Industry payments across NV — which companies pay providers there.